INTRODUCTION
Exhausted CD8 T cells (Tex cells) often develop during chronic infections and cancer and prevent optimal control of disease. They have functional defects, co-express multiple inhibitory receptors (IRs), and develop an altered transcriptional, epigenetic, metabolic, and differentiation program (Wherry and Kurachi, 2015) . Novel immunotherapies target IRs expressed by Tex cells such as PD-1 or CTLA-4 and are having dramatic effects in cancer patients with potential applications in other settings (Callahan et al., 2016) . Tex cells have been implicated in the response to checkpoint blockade, but the underlying immunological mechanisms of therapeutic response or failure in humans remain poorly understood. Recent epigenetic studies in mice and humans indicate that Tex cells represent a unique T cell lineage, compared to functional effector T (TEFF) cells and memory T (TMEM) cells Philip et al., 2017; Sen et al., 2016) . The Tex cell epigenetic landscape changes relatively little after PD-1 pathway blockade mediated re-invigoration , suggesting that Tex cells are a stable, distinct, and disease-relevant cell type.
Specific characteristics of Tex cells can vary in different disease settings (Wherry and Kurachi, 2015) . It has been unclear whether the diverse descriptions of exhaustion represent technical differences (e.g., choice of IRs examined), conceptual differences (e.g., about the degree of dysfunction), or diseaserelated features of Tex cells. Identifying and monitoring changes of Tex cells in humans has been challenging since many molecules expressed by Tex cells are also identified in other T cell subsets or expressed by recently activated cells. Moreover, different subsets of Tex cells have been defined that include progenitor and more terminally exhausted populations. These Tex cell subsets can be identified by T-bet, Eomes (eomesodermin), T cell factor (TCF)1, and PD-1 expression, and additional heterogeneity may exist based on follicular homing molecules such as CXCR5 (Blackburn et al., 2008; He et al., 2016; Im et al., 2016; Paley et al., 2012; Utzschneider et al., 2016; Wu et al., 2016) . 
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Human Mice *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** ** (legend on next page) exhaustion that is tuned differently to the precise disease setting. An approach that identifies and interrogates the heterogeneity of Tex cells and relates this information to disease status could provide new insights and opportunities for intervention based on manipulating Tex cells.
In this study, we developed a systems immunology approach to identify and deeply interrogate Tex cells in human disease. At the center of this approach is the development of a core exhaustion signature that integrates transcriptomic and epigenomic profiling of Tex cells in the chronic lymphocytic choriomeningitis virus (LCMV) system and then distills this mouse epigenomic signature into a robust and stable Tex cell gene expression signature that translates to human biology in HIV disease and human lung cancer. Deep mass cytometry profiling combined with bioinformatic analysis of the high-dimensional data allowed the identification of a set of multi-parametric exhaustion phenotypes. These data then distinguished 9-12 Tex cell clusters as well as subsets reflecting canonical T cell differentiation states, such as naive T (TN), TEFF , TMEM, and tissue-resident memory T (TRM) cells. Using this framework, we defined an ''exhaustion score'' for each cluster based on functional features. Linking changes in these Tex cell clusters to disease parameters in HIV and lung cancer defined subtypes of Tex cells more prominently impacted by antigen (viral load) versus environment (i.e., low CD4/CD8 ratio, CD4 counts) and revealed a conserved Tex cell program-but also changes in the diversity of exhausted subpopulations in HIV compared to lung cancer. These data now provide a resource to identify Tex cell populations with distinct patterns of expression of IRs, cytotoxic molecules, and transcription factors that may be relevant for designing checkpoint blockade therapies, but they also suggest possible relationships between Tex cell subtypes. These data provide a novel resource that should aid future studies and improve our understanding of exhaustion in chronic infection, autoimmunity, and cancer.
RESULTS
Identification of Genes with Unique Expression Patterns in Tex Cells
Tex cells undergo major transcriptional changes that distinguish them from TN, TEFF, and TMEM cells ( Figure 1A ) (Wherry and Kurachi, 2015) . Functional and transcriptional features of exhaustion arise after $2 weeks of chronic infection Doering et al., 2012) . We hypothesized that a core signature of genes specifically regulated in Tex cells during chronic LCMV infection could be used to identify and monitor Tex cells in other settings. We aimed to identify a focused set of highly exhaustionbiased genes, validate it against data from other settings of exhaustion, and then use epigenetic information for individual genes to further refine the signature. This signature could then enable the development of a comprehensive single-cell protein-based method for interrogating the biology of human Tex cells by mass cytometry. Thus, we first identified genes that specifically displayed increased or decreased expression in virusspecific Tex cells during chronic LCMV infection compared to TN, TEFF, and TMEM cells in acute resolving LCMV Armstrong infection ( Figures 1A and 1B) . These criteria identified genes highly biased to Tex cells compared to activation-related genes found in TEFF cells, such as Cd38. Other genes such as Havcr1 encoding Tim-3 that were also expressed by TEFF were not included. We validated the selection of genes by gene set enrichment analysis (GSEA) (Subramanian et al., 2005) comparing Tex cells isolated after 30 days of clone 13 infection to TMEM, TEFF, and TN cells ( Figure 1C ). We also investigated whether this signature would enrich in subsets of Tex cells (Blackburn et al., 2008; Im et al., 2016; Paley et al., 2012) . GSEA showed strong enrichment in signatures of the more terminally exhausted Tex cell subset expressing high levels of PD-1 or Tim-3 compared to the progenitor subset of Tex cells expressing lower levels of PD-1 or CXCR5 ( Figure 1D ) (Blackburn et al., 2008; Im et al., 2016) . However, the genes selected also enriched in the less terminal subsets of Tex cells if these cells were compared to TEFF rather than terminal Tex cells (data not shown), suggesting high sensitivity of this signature. Moreover, this exhaustion signature strongly enriched in tumor-infiltrating lymphocytes (TILs) from melanoma patients versus peripheral blood and in HIV-specific T cells from HIV progressor patients versus elite controllers ( Figure 1E ), in agreement with previous reports (Baitsch et al., 2011; Quigley et al., 2010) . We also noted that a number of exhaustion genes were enriched in elite controllers, indicating that the signature also included genes that might be useful for discriminating less dysfunctional exhaustion states ( Figure 1E ). Extending these analyses to other transcriptomic datasets also identified more exhausted human T cell populations in silico such as CD39+ hepatitis C virus (HCV)-specific CD8 T cells (Gupta et al., 2015) ( Figure 1F ; Table  S1 ). Leading edge analysis identified genes strongly contributing to the enrichment, including ENTPD1 (encoding CD39), CTLA4, PDCD1, and CD38, that were common to enrichment for TILs from melanoma and chronic HCV infection ( Figures 1G and 1H ). In sum, these analyses identified a transcriptomic signature of Tex cells in chronic LCMV infection that was shared across species and disease types. Moreover, the patterns of enrichment Sen et al., 2016) . Starting with the differentially expressed genes identified in Figure 1 , 313 and 182 exhaustion-specific genes (with increased or decreased expression in Tex cells, respectively) also contained associated Tex cell-related epigenetic (e.g., enhancer) changes (Figures 2A and 2B ; Table S2 ). These genes included those with more accessible OCRs close to genes encoding IRs (e.g., Pdcd1, Tigit, and Ctla4), ectoenzymes implicated in metabolic regulation (e.g., Cd38 and Entpd1), chemokines and cytokines (e.g., Xcl1), and transcription factors (e.g., Eomes, Ikzf2, and Tox) ( Figure 2B and Table S2 ). Genes with reduced accessibility of OCRs linked to decreased expression in Tex cells (e.g., Ccr7, Il7r, Nt5e, Tcf7, and Lef1) were also identified (Table S2) . Tex cell genes with associated OCR changes contributed significantly more frequently to the enrichments observed in the comparisons of Tex cell populations across diseases in Figure 1 compared to genes without a Tex cell-related epigenetic change ( Figure 2C ). This feature was manifest by significantly higher GSEA leading edge contributions ( Figure 2C ; Table S3 ), but different Tex cell gene contribution to the leading edge varied depending on the comparison ( Figures 2D and 2E ). Gene ontology (GO) term analysis indicated that ''epigenomically selected'' exhaustion genes with increased expression and enhancer accessibility were enriched in immune activation and regulation of phosphorylation pathways, whereas genes with decreased expression and reduced enhancer accessibility enriched for metabolic processes, among others ( Figure 2F ). Thus, key genes distinguishing Tex cells from canonical T cell subsets are revealed by a combination of unique transcriptomic expression patterns and associated epigenetic changes. These uniquely regulated genes are strong candidates for biomarkers of exhaustion across diverse disease types.
CD8 T Cells Expressing Exhaustion Genes Are Biomarkers of HIV Disease Progression
Tex cells are a hallmark of chronic HIV infection. We hypothesized that converting the population-based epigenomic exhaustion signature defined above to a single-cell profiling approach could provide insights into the diversity of Tex cells in HIV disease. We thus constructed a mass cytometry panel that integrated 16+ epigenomically selected exhaustion-related gene products together with other T cell markers for defining lineage and other differentiation states (Table S4 ). The genes selected for further analysis by cytometry by time of flight (CyTOF) were chosen, in part, based on the availability of high-quality antibodies for cytometry analysis. Other epigenomically selected genes are also available for future analyses, including ADAM19, BHLHE41, DUSP4, GLP1R, GPR65, GPR155, IFI27, IFI44, PRDM1, PTPN13, RGS16, and SLC22A15 (Tables S2 and S3) . The exhaustion genes encoding proteins selected for this CyTOF panel had a high leading edge contribution to the enrichment of the exhaustion signature in different diseases (Figures 3A and 3B) . To interrogate the discriminatory potential in single-cell datasets and to test how the exhaustion markers selected for the CyTOF panel compared to the larger epigenomically selected list, we used gene set variation analysis (GSVA) of a published CD8 T cell single-cell transcriptomic dataset from human melanoma TILs (Tirosh et al., 2016) . Both the total epigenomically selected genes and the subset selected for CyTOF discriminated considerable variation in the single-cell RNA sequencing (scRNA-seq) data, with similar discriminating potential ( Figure S1 ), indicating that this subset of genes was emblematic of key features of exhaustion.
We next applied this CyTOF panel to analysis of peripheral blood mononuclear cells (PBMCs) from healthy control subjects (HCs) and patients with active HIV infection as well as HIV patients on anti-retroviral therapy (ART) ( Table S5 ). In subsequent analyses, we also included samples from lung cancer patients including PBMCs, macroscopically uninvolved lung tissue, and TILs. We first examined classically defined TN, TEFF, effector memory (TEM), central memory (TCM), and terminally differentiated effector memory RA (TEMRA) as well as PD-1+ CD8 T cells for the expression of epigenomically selected exhaustion markers ( Figures 3C and 3D ). PD-1+ cells expressed more of these markers than any of the other phenotypically defined CD8 T cell populations, whereas TN and TCM cells expressed molecules linked to decreased expression by Tex cells ( Figure 3C ).
We next examined the correlation between expression of individual exhaustion molecules with the CD4/CD8 ratio, an established metric of severity of HIV disease ( Figure 3D ). Molecules Genes specifically regulated in Tex cells from Figure 1 were analyzed for epigenetic changes in ATAC-seq datasets from LCMV infection (GEO: GSE86797, GSE87646). Genes are detailed in Table S2 . Tables S1 and S3 . Genes with an associated OCR change displayed higher leading edge involvement. ***p < 0.001. Lines in the box and whisker plots indicate the highest and lowest observations, whereas the boxes span the upper and lower interquartile range. (D and E) The leading edge contribution of exhaustion signature genes with an associated OCR change is shown as a binary heatmap for genes up-(D) and downregulated in exhaustion (E) (rows indicate genes, columns individual GSEA comparisons, and red leading edge contribution; for details, see Table S3 ). (F) GO term analysis of the exhaustion-specific genesets with associated OCR changes. The 20 GO terms with the lowest p values are shown. predicted to be decreased in Tex cells correlated with health, mild disease, and a higher CD4/CD8 ratio (e.g., CCR7, CD73, and CD127), whereas molecules predicted to be increased in Tex cells correlated with low CD4/CD8 ratios, indicating advanced disease (e.g., 2B4, CD38, CD39, Eomes, PD-1, TIGIT, and TOX) ( Figure 3D ; Figure S2 ). Correlation matrix analysis identified sets of highly co-regulated exhaustion-related molecules in HIV, such as PD-1, Eomes, 2B4, TIGIT, and CD38 ( Figure 3E ; Figure S3 ). Several of these molecules (i.e., CD38 and PD-1) are known indicators of immune activation and exhaustion in progressive HIV infection, though others such as TOX are less well understood. Some markers predicted to be highly expressed in exhaustion did, however, only display trends toward enrichment in severe HIV (LAG-3 and CTLA-4) or were even associated with less severe disease (CD7 and Helios), suggesting more complex relationships are captured poorly by the analysis of single markers. Indeed, for individual patients with HIV-AIDS or lung cancer, more extreme Tex cell phenotypes existed that were identified, for example, by co-expression of CD7 and PD-1 ( Figure 3F ). Moreover, other molecules that displayed no obvious, negative (CTLA-4, LAG-3, and CD39) or a complex (Helios) co-expression pattern with PD-1 in HCs became positively associated with PD-1 in disease, pointing toward the need for high-dimensional analysis of Tex cells.
A High-Dimensional Single-Cell Map of Exhaustion Reveals Distinct Locations of Virus-Specific T Cells and TILs in the Tex Cell Landscape
To visualize the complex Tex cell phenotypes defined by this CyTOF panel, we first used a t stochastic neighbor embedding (tSNE)-based dimensionality reduction approach integrating the information from exhaustion marker expression of non-naive CD8 T cells into an ''exhaustion map'' ( Figure 4A ). Samples from different batches were quality controlled and displayed similar results in the high-dimensional analysis ( Figure S4 ). Cells with closely related high-dimensional phenotypes localized in neighboring areas of the map ( Figure 4B ). For example, PD-1 expression largely overlapped with Eomes, multiple other IRs, and a paucity of CD127 expression ( Figure 4B ). Other regions displayed expression of other Tex cell genes (e.g., CD38, CD39, Helios, and TOX) and/or different patterns of PD-1 co-expression ( Figure 4B ). This exhaustion map was used to interrogate differences in exhaustion states across patients and diseases ( Figure 4C ). Tetramer+ virus-specific CD8 T cells targeting cytomegalovirus (CMV) and influenza virus (FLU) epitopes localized to distinct areas of the exhaustion map compared to HIV-specific CD8 T cells, confirming the ability of this approach to distinguish known differentiation patterns of virus-specific CD8 T cells ( Figure 4D ). Moreover, the HIV-specific CD8 T cells, but not FLUspecific and few CMV-specific populations, overlapped with the PD-1+ part of the exhaustion map ( Figures 4B and 4D ). Thus, examination of virus-specific CD8 T cells validated the exhaustion map in the ability distinguish HIV-, CMV-, and FLU-specific populations.
We then examined all non-naive CD8 T cells from HCs and HIV patients on and off therapy. Concatenated data shown in Figure 4E revealed distinct distributions of T cell populations in these cohorts, pointing to the possibility of using such ''exhaustion fingerprints'' for dissecting disease states. Although Tex cells have been reported in viral infections as well as cancer, it remains unclear whether there are common versus distinct features of Tex cells in different diseases. To address this question, we next examined TILs isolated from lung cancer patients and T cells isolated from macroscopically unaffected adjacent tissue ( Figure 4F ). TILs mapped to regions with some overlap with HIVspecific T cells but also displayed distinct features ( Figure 4F ). However, the lung tissue microenvironment might contribute to the TIL signature. After removal of the phenotypic signature of cells from the uninvolved lung tissue, TIL-enriched features became apparent that included regions with partial overlap with HIV-specific CD8 T cells and co-expression of PD-1, other IRs, and Eomes (top of exhaustion map) but also other regions of the exhaustion landscape highly enriched in TILs with PD-1 and CD39 co-expression (Figures 4B, 4F, and 4G) . In sum, high-dimensional profiling of Tex cells identified distinct features of the differentiation landscape for HIV-specific CD8 T cells and TILs.
High-Dimensional Tex Cell Cluster Dynamics in HIV Infection
We hypothesized that additional insights into these high-dimensional data and disease relevance could be achieved by a non-redundant high-dimensional analytical approach using phenograph ( Figure 5A ) that enables high stability of cluster identification without downsampling or dimensionality reduction (Melchiotti et al., 2017) . Phenograph analysis Table S4 . Cytokines and chemokines were analyzed using a dedicated panel (see Table S6 ). (B) Genes selected for CyTOF had significantly higher leading edge contribution in the GSEA analyses of Tex cells compared to the remaining exhaustion genes (***p < 0.001) and showed similar ability to discriminate Tex cells in single-cell transcriptomic data (see Figure S1 ). Lines in the box and whisker plot indicate highest and lowest observations, whereas the boxes span the upper and lower interquartile range. (C) Exhaustion markers were analyzed on canonical CD8 T cell populations (TN, TCM, TEM, and TEMRA) and total PD-1+ CD8 T cells in HCs and patients with HIV and lung cancer. Heatmap depicts exhaustion marker expression by median metal intensity (MMI) on concatenated CD8 T cell data from PBMCs (n = 35; see Table S7 ). (D) Linear regression analysis versus CD4/CD8 ratio was performed for marker expression in patients with HIV infection and HCs using percent positive or MMI as indicated. Each dot represents an individual patient's CD8 T cells (n = 75 samples from 48 HIV patients and HCs were analyzed; higher sample number indicates longitudinal samples when available; for details see Table S7 ). Green, positive correlation; red, negative correlation. Similar results were obtained in a repeat analysis on a different mass cytometer ( Figure S2) . (E) These data were further analyzed for cross-correlation of exhaustion marker expression estimated by pairwise method (see also Figure S3 ). (F) The expression of indicated exhaustion markers on CD8 T cells is plotted versus PD-1 in a representative HC, an untreated HIV patient with a CD4/CD8 ratio of 0.06 typical of AIDS, and tumor-infiltrating lymphocytes (TILs) isolated from a lung cancer patient. 
. An Exhaustion Map Allows Comparison of Tex Cells across HIV and Lung Cancer
(A) An exhaustion map was generated by tSNE-based dimensionality reduction on 48 samples (see Table S7 ) using information about expression of 16 exhaustion markers (see Table S4 ) on non-naive (CD45RAÀCCR7À) CD8 T cells.
(legend continued on next page)
identified 25 clusters based on expression of exhaustion markers (30 clusters were computed, but clusters c14, c20, c22, c24, and c30 contained few events and were excluded from further analyses; see STAR Methods). Some clusters were identified that phenotypically represented TN and TCM cells (clusters such as c13, c15, or c21) or populations with features of TEM (e.g., clusters c10 and c11) or TEMRA-like cells (e.g., clusters c10, c9, and c23) ( Figures 5B and 5C ). In contrast, the cluster contribution to PD-1+ CD8 T cells showed more diversity, and no single cluster contributed to more than 15% of the population ( Figure 5B ), suggesting a high resolution of this approach for Tex cell subset discrimination. Approximately 9-12 clusters contained putative Tex cells based on co-expression of 3 or more (up to 9) IRs (c1, c2, c3, c4, c9, c16, c18, c19, c27, c28, and c29), whereas 9 clusters were associated with TN and/or TCM phenotypes and contained cells with <3 IRs. TEM and TEMRA phenotype cells were contained in 3-8 distinct clusters. Notably, 3 of these clusters contained cells with <3 IRs, but the other clusters containing classically defined TEM and TEMRA also contained clusters expressing IRs ( Figure 5C ). This observation likely reflects the fact that phenotypically exhausted cells are mostly CD27+CD45RAÀ (Bengsch et al., 2010; Huang et al., 2017) and fall into the CD8 T cell subset defined by the classic definition of TEM (CCR7ÀCD45RAÀ). Thus, the high-dimensional approach is necessary to parse these different CD8 T cell populations. Applying this approach to virus-specific CD8 T cells revealed distinct cluster distribution patterns for HIV-, FLU-, and CMV-specific CD8 T cells ( Figure 5D ). Cluster c10, which contained cells with high expression of T-bet, Granzyme B, Perforin, and CD57, a phenotype often associated with TEMRA and/or T cell senescence, was strongly enriched in CMV-specific CD8 T cells (Figure 5D ). In contrast, cluster c15 with hallmarks of TCM cells was enriched in FLU-specific CD8 T cells from the blood ( Figures  5B-5D ), whereas FLU-specific CD8 T cells from lungs were enriched in clusters c18 and c28, which expressed CD103, a molecule often expressed by TRM cells ( Figure S5 ) (Schenkel and Masopust, 2014) . HIV-specific CD8 T cells enriched in clusters with high expression of exhaustion markers, and the distribution of these Tex cell clusters was altered in ART-treated HIV patients ( Figures 5C and 5D) . Notably, many cluster composition changes found in HIV-specific CD8+ T cells, such as the increase of c27 and decrease of c29 and c3 in ART-treated patients, were also observed on the global CD8 level ( Figure 5E ).
T cell exhaustion was originally defined by altered and often poor function (Zajac et al., 1998) . However, Tex cells are not functionally inert. Rather, they are characterized by reduced interferon (IFN)-g production and a poor ability to simultaneously produce IFN-g and tumor necrosis factor (TNF), lack of interleukin (IL)-2, and reduced cytotoxicity, but they often retain the ability to make some IFN-g and also robustly produce chemokines (Betts et al., 2006; Crawford et al., 2011; Fuller and Zajac, 2003; Wherry et al., 2003) . Our transcriptomic and epigenomic profiling also indicated upregulation of chemokines and cytokines (e.g., XCL-1, IL-10, IL-21, and amphiregulin) in Tex cells (Table S2) . It remained unclear whether the high-dimensional clusters identified by phenotype also reflected functional characteristics of exhaustion. We thus interrogated functional features of exhaustion and their relationship to the clusters determined above by stimulating CD8 T cells from viremic HIV patients and examined functionality ( Figure 3A ; Table S2 ) using a panel built on the framework of 13 phenotypic exhaustion markers (Table S6 ). Mapping chemokine and cytokine production to phenotypic clusters identified distinct cluster function ( Figure 5F ). Expression of CCL3/4, XCL1, and IL-21 was identified in clusters such as c2, c16, and c29 with other features of exhaustion. In contrast, amphiregulin stained primarily in clusters with naive or memory phenotypes (e.g., c13, c15, c17, and c21; Figure 5F ) rather than Tex cell clusters, though the reasons for this disparity between the genomic and protein data are currently unclear. Cells that retained IFN-g production but lost TNF production (i.e., reduced polyfunctionality) were prominently associated with the clusters c3, c16, and c29, which also co-expressed many IRs ( Figures 5C and 5F ) consistent with exhaustion. To enable comparisons, we developed a functional exhaustion score (FES) that increased for functional hallmarks of exhaustion (e.g., loss of TNF or IL-2 production, upregulation of chemokines) and decreased with the presence of effector or memory functionality (e.g., IL-2 production or IFN-g and TNF co-production) (see STAR Methods). The highest FES was observed for cluster c29, which phenotypically resembled highly exhausted T cells based on the co-expression of 6-7 IRs and other features of Tex cells ( Figures 5C and 5F ). This analysis identified 9 clusters with high FESs that also mapped to clusters with high IR co-expression, such as the two clusters with the highest FESs (''top 2,'' c3 and c29). However, 3 clusters (c18, c19, and c28) that co-expressed 3-4 IRs had intermediate to low FESs. As expected, TCM, TEM, and TEMRA cells enriched for clusters with low FESs (Figure 5F ). Notably, even HCs had detectable, albeit low, frequencies of Tex cell clusters, including especially those with lower FESs such as c5, c9, c16, and c27 ( Figures 5E and 5G) .
We next asked how these clusters changed with HIV disease severity and after control of viral replication by ART. Tex cell clusters such as c2 and c29 were expanded in advanced HIV infection but were decreased in ART therapy ( Figure 5E ). Clusters c1, c2, c4, c11, c18, c28, and c29 were positively associated with both high viral load and low CD4/CD8 ratio ( Figure 5G , left upper panel). Other clusters including the Tex cell clusters c5, c9, and c27 as well as TN/TCM clusters (e.g., c15 and c17) were associated with low viral load and higher CD4/CD8 ratio. In contrast, clusters such as c10, a cluster with characteristics of TEM and TEMRA, low FES, and abundant in CMV-specific T cells ( Figure 5D ), were more strongly associated with low CD4/CD8 ratio than changes in viral load, and c10 in particular was expanded in HIV infection, suggesting a bystander effect ( Figure 5G ). Many Tex cell clusters were linked to severe HIV disease (e.g., c29, c2, c3, and c4) and displayed co-expression of IRs (e.g., PD-1, 2B4, CD160, and TIGIT) and high Eomes, a phenotype consistent with severe exhaustion (Figures 5C and 5G) . Interestingly, some clusters were enriched in mild HIV, expressed molecules consistent with progenitor Tex cells (e.g., CD127; some TCF1: c16 and c27) in addition to IRs and other exhaustion markers, and c16 included CXCR5+ cells ( Figures 5C and 5G) . A link to mild disease was also observed for a cluster with low PD-1 but high 2B4, CD160, and TIGIT and high expression of cytotoxic molecules (c9), suggesting preserved cytotoxicpotential and features of exhaustion in the absence of high PD-1. Together, these results point to multiple subtypes of Tex cells differentially linked to HIV disease progression or therapy and identified features of Tex cells and other T cell subsets that are preferentially associated with changes in viral load, immune dysregulation (captured by CD4/CD8 ratio), and response to ART.
Distinct Functional, Phenotypic, and Transcriptional Features of Tex Cell Clusters
To test whether these analyses could distinguish Tex cells from TEFF , we generated TEFF cells in vitro starting with total PBMCs or sorted TN, TCM, TEM, or TEMRA cells and then examined the functional and phenotypic profile of the resulting TEFF cells. TEFF cells had high polyfunctionality, IFN-g, and TNF coproduction and a low FES ( Figure 6A ). In this analysis, CD39, LAG-3, Helios, and CTLA-4 were higher on activated TEFF cells, whereas Tex cell clusters displayed higher expression of Eomes, TOX, 2B4, and TIGIT, among other molecules ( Figure 6B ). This high-dimensional approach clearly distinguished Tex cell from TEFF, a distinction that has been challenging using other approaches based on individual markers. As expected, Tex cell clusters did not represent typical TN, TCM, TEM, or TEMRA populations; instead, 7 of the top 9 clusters with the highest FESs showed high PD-1 expression ( Figure 6C ). To test how the FES related to the high-dimensional phenotypes, we plotted the phenograph-derived clusters using tSNE ( Figure S6 ) and projected the FES onto this simplified cluster map ( Figure 6D ). Clusters with positive exhaustion scores fell in close proximity ( Figure 6D) . Analysis of the transcription factor expression patterns in Tex cell clusters revealed high Eomes and TOX in clusters with a high FES ( Figure 6E ). In contrast, high T-bet and Helios were present in Tex cell cluster c9, which expressed many cytotoxic molecules. Finally, TCF1 was expressed by a subset of Tex cells, including clusters c1 and c16, but this transcription factor was highest in non-Tex cells ( Figure 6E ), consistent with the major role for TCF1 in TN and TMEM cells. These results showed that high-dimensional Tex cell clusters display distinct phenotypic, transcriptional, and functional properties.
Use of Tex Cell Clusters to Interrogate Disease Associations
We next asked whether the distribution of Tex cell clusters might inform about disease state. We thus identified the 9 Tex cell clusters with highest FESs (c1, c2, c3, c4, c5, c9, c16, c27, and c29, among which c3 and c29 were highest [top 2]) and grouped them based on correlation with CD4/CD8 ratio and viral load in viremic untreated HIV patients into those linked to severe disease (''disease-associated Tex cells'' [DATs; c1, c2, c4, and c29]) and those associated with mild disease (''health-associated Tex cells'' [HATs; c9, c16, and c27]) ( Figure 6F ). We then analyzed FLU-, CMV-, or HIV-specific T cells for the sum of the frequency of the top 2 or top 9 Tex cell clusters and for the ratio of clusters linked to severe (disease) versus mild (health) HIV infection (Tex ratio: DAT/HAT). HIV-specific T cells had higher frequencies of exhausted clusters and also a higher Tex ratio compared to FLU-and CMV-specific T cells ( Figure 6G ). The Tex ratio also revealed changes during ART therapy that were characterized by an increase in HATs ( Figure 6G ). These findings observed in HIV-specific CD8+ T cells could be extended to total CD8 Table S7 ). Canonical CD8 T cell populations and total PD-1+ T cells were analyzed for their composition based on the phenograph analysis. The top 5 phenograph clusters within TN, TCM, TEM, TEMRA, and PD-1+ CD8 T cells are shown. (C) Phenograph clusters were tested for expression of T cell markers using manual gating. Heatmap indicates expression of markers or marker combinations (using [+] or [À] , as in PD-1+CD39+) or median metal intensity (MMI; e.g., TOX). Row-and column-based clustering was performed using Pearson's correlation. The heatmap coloring reflects Z scores after row normalization, as indicated. (D) The contribution of phenograph clusters to virus-specific T cell responses from HIV patients and HCs detected via tetramer staining was analyzed; the top 5 clusters are shown (n = 24 tetramer responses; CMV n = 4, FLU n = 5, and HIV n = 15). Changes in phenograph cluster composition of HIV-specific T cells on or off anti-retroviral therapy (ART) are displayed. (E) The distribution of phenograph clusters in HCs and HIV patients (total n = 25) with differing disease states (CD4/CD8 ratio for viremic ''Severe'': <0.2, ''Intermediate'': 0.2-0.5, and ''Mild'': >0.5) is shown. The coloring reflects cluster assignment. The mean frequency of each cluster for each patient population is depicted by the size of the corresponding bar. (F) Viremic HIV and control samples were stimulated with phorbol 12-myristate 13-acetate (PMA)/ionomycin and analyzed for cytokine expression by cluster mapping using phenograph classify function and the scaffold parameters detailed in Table S6 . Heatmap indicates gated expression of markers or marker combinations and the functional exhaustion score (FES) (see STAR Methods). Column-based clustering using Pearson's correlation metric was performed. Rows are arranged by FES. Values displayed are column normalized. (G) The correlation of each phenograph cluster frequency with key parameters of HIV disease progression in viremic HIV patients (i.e., CD4/CD8 ratio and viral load) was plotted (upper left panel). This coordinate system displays the relative frequency of each cluster in HCs, HIV patients with untreated disease, and patients on ART therapy (remaining panels). The dot size corresponds linearly to cluster relative abundance; the color corresponds to the FES. T cells that showed an enrichment of the top 2 and top 9 Tex cell clusters, a higher DAT/HAT ratio in viremic HIV patients compared to HCs, and some reduction of this ratio upon therapy ( Figure 6H ). Although the correlations associating clusters with severe or mild HIV were derived from viremic untreated patients (Figure 5 ), the correlations of Tex cell clusters with the CD4/CD8 ratio remained stable in ART-treated patients ( Figure S6) . Thus, detailed analysis of Tex cell biology provided insight into changes in HIV disease and therapy and may serve as a framework to understand specific features of exhaustion involved in different stages of disease and guide novel therapeutic approaches.
Organ-and Disease-Specific Changes in Tex Cells in Lung Cancer
One unresolved question is whether key features of exhaustion are shared across different diseases and/or tissue sites. To interrogate this issue, we examined CD8 T cells from patients with newly diagnosed lung cancer using samples from peripheral blood, lung tumors, and macroscopically unaffected lung tissue. Clusters with TN and TCM-like features (c13, c15, and c21) were reduced in lung cancer patient PBMCs compared to HCs (Figure 7A ). Larger changes in cluster distribution were observed between the blood, the lung tissue, and TILs, including an enrichment in Tex cell clusters c2 and c29, as well as the TEM/TEMRA cluster c10 in TILs ( Figure 7A ). Clusters expressing CD103 were enriched in the uninvolved lung tissue and TIL samples (e.g., c11, c18, and c28), suggesting a lung tissue imprint on both Tex cells and non-exhausted populations ( Figure 7A ). The TRM-like populations also included FLU-specific cells ( Figure S5 ). Thus, cells with general features of Tex cells in the respiratory tract of lung cancer patients overlap with those observed in blood, but this anatomical location was also associated with alterations in Tex cells and non-exhausted cell populations that may relate to tissue-specific programming.
Enrichment of Tex Cell Signatures in Poorly Functional Lung Cancer TIL Populations
To interrogate how these TIL clusters related to function, IFN-g production was examined after short-term in vitro stimulation (Figure 7B ). Samples were then grouped into high and low IFN-g producers. We plotted the changes in cluster distribution between CD8 T cells isolated from HCs or lung cancer patients and also compared TILs with high versus low IFN-g functionality (Figure 7C ). Blood from lung cancer patients had a notable loss of TN and TCM clusters (c13 and c15) and enrichment of Tex cell clusters c4 and c9. Lung tissue was enriched for clusters such as c11, c18, and c28 that expressed CD103 ( Figure 7C ). In more functional TIL populations, the non-Tex cell clusters c11 and c18 as well as cluster c28 were enriched, whereas in TILs with low functionality, Tex cell clusters c4, c27, and c29 were overrepresented ( Figure 7C ). We investigated whether the results from HIV could be used to inform exhaustion and disease in the tumor context. Compared to PBMCs, CD8 T cells from lung and TILs enriched in the sum of the top 2 or top 9 Tex cell clusters identified above ( Figure 7D) . Moreover, the DAT/HAT ratio strongly increased in the TIL samples compared to the adjacent lung (Figure 7D) . Examining specific clusters, we found that c3, c4, and c6 were enriched in TILs with low IFN-g production, with similar trends for c8 and c29 ( Figure 7E ). These clusters co-expressed PD-1 and Eomes, and many also had high co-expression of multiple IRs ( Figures 5C and 7F ). In contrast, c28 was overrepresented in tumors with higher IFN-g production ( Figures 7C and  7E ). This cluster expressed CD103 as well as some PD-1 and other exhaustion-associated molecules (e.g., CD39, CTLA4, and TOX) but lacked expression of other features of severe exhaustion, such as Eomes and or high expression of other IRs (e.g., 2B4, CD160, and TIGIT) and also did not have a high FES in the HIV data. Although high-and low-function TILs contained HAT clusters (as defined above), low-function TILs were substantially enriched in DATs ( Figure 7G ). These analyses revealed conserved Tex cell biology across HIV and cancer, with additional insights into disease-specific enrichments. They demonstrate the ability to use an epigenomically guided CyTOF approach to connect the differentiation landscape of Tex cells across tissues, disease type, and disease severity. Moreover, this resource reveals common Tex cell biology and disease-specific features.
DISCUSSION
We developed a systems immunology pipeline to profile the heterogeneity of Tex cells in human disease. This pipeline integrated information from bulk transcriptomic and epigenomic datasets to develop a novel, focused single-cell proteomic profiling approach. The ability to identify Tex cells at the single-cell level (D) Phenograph clusters were plotted based on a tSNE analysis using exhaustion marker expression as outlined in Figure S3 and colored by the FES. (E) Clusters were analyzed for transcription factor expression and arranged based on FES. Heatmap is clustered by rows using Pearson's correlation.
(F) Tex cell clusters with high FESs were plotted versus correlation of cluster frequency with CD4/CD8 and viral load.
(G) Virus-specific T cells identified in PBMCs from HCs and HIV patients were analyzed for the prevalence of the top 2 (upper graph) and top 9 (middle graph) clusters with highest FES (sum of percentages for top 2 and top 9 clusters is displayed). The TEX ratio (lower graph) is shown as the sum of clusters defined to be disease associated (DAT; i.e., linked to severe HIV) divided by the sum of clusters defined to be health associated (HAT; i.e., linked to mild HIV), as in Figure 6F .
(H) As in (G), top 2, top 9, and TEX ratio was determined for CD8+ T cells from PBMCs of HCs and HIV patients and displayed by HIV disease stage. Lines in the box and whisker plot indicate the hightest and lowest observation, whereas the boxes span the upper and lower interquartile range. Heatmap coloring in (A), (B), and (E) reflects Z scores after column normalization. by cytometric approaches has remained challenging due to the lack of a distinct marker of Tex cells. For example, many individual proteins implicated in exhaustion, such as PD-1, are also expressed by other activated cells. Here, we used an epigenomic-driven mass cytometry approach to identify Tex cell populations in humans with chronic infection and cancer. Tex cells identified using this approach displayed differential expression of exhaustion markers compared to TEFF , TMEM, and TN cells, as predicted. Notably, Tex cells were even detected in HC blood, suggesting that exhaustion is a normal aspect of T cell biology that is amplified in specific disease settings. In HIV infection, more dysfunctional Tex cell subpopulations were enriched in more severe disease, and similar Tex cell clusters were found in more dysfunctional TILs in lung cancer. Applying such approaches to distinct diseases will facilitate identification of Tex cell features associated with specific types of diseases and anatomical locations and will guide understanding of changes in Tex cell populations with immunotherapeutic interventions in chronic infections, cancer, and even autoimmunity.
We identified 12 putative Tex cell clusters with considerable heterogeneity in the precise pattern of IR and transcription factor co-expression. Eomes was a prominent feature of Tex cell clusters linked to disease severity in HIV and TILs. Notably, however, c18, c19, and c28 expressed 4-5 IRs, but they lacked Eomes and had low FESs. Among these, c19 and c28 (but not c18) expressed TOX. Thus, based on transcription factors and IRs, not only was it possible to identify phenotypically exhausted cells in human chronic infections and cancer (as predicted from previous work) but it was also possible to identify discrete types of Tex cells present in different diseases. Interrogating T cell function helped validate the nature of putative Tex cell clusters and also provided a framework to link changes in cluster distribution to disease. Often, changes in polyfunctionality, rather than production of IFN-g alone, more accurately reflect T cell exhaustion (Betts et al., 2006; Fuller and Zajac, 2003; Wherry et al., 2003) . The residual functions of Tex cells may be important in establishing a host-pathogen or host-tumor equilibrium. For example, in chronic simian immunodeficiency virus (SIV) infection, virus-specific CD8 T cells become exhausted (Velu et al., 2009) , but CD8 T cell depletion causes increases in viral load and progression to AIDS (Schmitz et al., 1999) . Here, using high-dimensional cytometry, we developed a FES that was linked to high-dimensional T cell phenotypes. The FES validated the phenotypically defined Tex cell clusters since clusters with a high FES had high co-expression of many exhaustion markers, such as IRs (e.g., c1 and c29) and high expression of Eomes in combination with PD-1 (e.g., c3 and c29). In contrast, a lower FES identified Tex cells with lower IR expression and higher levels of CD127, TCF1, and/or CXCR5 expression (e.g., c16 and c27), phenotypes previously associated with more functional Tex cells (Blackburn et al., 2008; Im et al., 2016; Paley et al., 2012; Utzschneider et al., 2016; Wieland et al., 2017) . Thus, the combined highdimensional epigenomically guided phenotypic and functional analysis accurately identified Tex cells and provides a resource to interrogate how changes in the Tex cell landscape are associated with disease.
Overall, this approach revealed several novel concepts about the biology of Tex cells in humans. First, Tex cells exist in HCs, albeit at low frequency, and are enriched in clusters with lower FESs. Second, both HIV and lung cancer were enriched for Tex cell subtypes that appeared severely exhausted by phenotype and FES (e.g., c3 and c29). These observations point to a common core biology of Tex cells present across diseases. Third, distinct clusters were overrepresented in HIV (e.g., c2) or lung cancer (e.g., c27 or c28), perhaps representing features of tissue location (e.g., CD103 in c28) or other disease-specific effects. Fourth, Tex cells were identified that were associated with better health in chronic disease. Clusters c9, c16, and c27 were associated with higher CD4/CD8 ratio and lower viral load in HIV infection and were preserved in HIV+ ART patients, suggesting a potential benefit to the host or enhanced durability based on cytotoxic molecule expression (c9), CD127 and TCF1 expression (c16 and c27), and/or CXCR5 co-expression with PD-1 (c16). Finally, many of the Tex cell clusters defined in HIV that associated with severe disease were also linked to poor TIL function (e.g., c3, c4, and c29). In lung cancer, a separate cluster with high CD103 expression, c28, was associated with more functional TILs, consistent with a low FES for this cluster in the HIV setting.
Heterogeneity in Tex cells has been identified in animal models that relate to either terminal exhaustion or, conversely, persistence and the ability to be reinvigorated by PD-1 pathway blockade (Blackburn et al., 2008; Im et al., 2016; Paley et al., 2012; Utzschneider et al., 2016; Wu et al., 2016) , but the role in human disease has remained unclear. Our approach resolved this heterogeneity in human Tex cell clusters. For example, c16 expressed Eomes and PD-1 but also moderate TCF1 and high CXCR5, suggesting a similarity to the described TCF1+ CXCR5+ subset (He et al., 2016; Im et al., 2016; Utzschneider et al., 2016; Wieland et al., 2017; Wu et al., 2016) . Some CXCR5 (B) Tumors were evaluated based on CD8 TIL IFN-g production following overnight anti-CD3 stimulation and stratified into high and low TIL functionality. (C) The relative frequency of each cluster is shown on the same exhaustion coordinate system as in Figure 6D and Figure S6 . (D) Sum of the frequencies for the top 2 and top 9 Tex cell clusters and TEX ratio were determined as defined in Figure 6 . Lines in the box and whisker plots (D and G) indicate the highest and lowest observation, whereas the boxes span the upper and lower interquartile range. (E) Clusters overrepresented in low or high functionality TILs are shown (for stacked bar analysis see Figure S5 ). Column height indicates mean of scattered dot plot +SEM. * indicates p < 0.05. c8: p = 0.07; c29: p = 0.08. (F) Bivariate plots indicate expression of markers of exhaustion, activation, tissue residency, and transcriptional programming for clusters differentially linked to tumor functionality. Plots display concatenated CD8 T cell data from lung cancer patients and HCs as assigned by phenograph clustering. (G) The sum of the frequencies of HAT or DAT clusters linked to mild or severe HIV was determined in the lung cancer cohort. TIL data were analyzed both as total aggregate data and separating the high and low functionality samples as shown in (B). DAT clusters enrich in the dysfunctional tumor microenvironment in lung cancer. and TCF1 expression was also observed in c1, and moderate CXCR5 expression was observed in c29, both clusters with higher FESs than c16, suggesting different degrees of exhaustion and potential precursor-progeny relationships among CXCR5+ and TCF1+ Tex cells. An additional implication of this heterogeneity is the differential expression of immunoregulatory targets. Identifying IR co-expression patterns on subsets of Tex cells with suspected progenitor capacity or on Tex cells with disease-specific enrichment might allow more effective immunotherapies. For example, clusters enriched in lung cancer TILs (e.g., c28) had prominent expression of CTLA-4 unlike Tex cells in the blood of HIV patients, suggesting potentially more benefit of targeting this molecule in cancer. Better understanding of Tex cell heterogeneity should provide insights into disease progression and can be used to identify target populations responding to therapy.
Recent epigenetic studies indicate that Tex cells constitute a distinct T cell lineage, and their fate appears largely epigenetically stable even after PD-1 pathway blockade Philip et al., 2017; Sen et al., 2016) . The epigenetic information about Tex cells used to construct our CyTOF panel allowed this high-dimensional single-cell approach to be anchored on genes/proteins that were ''fate-specific'' for T cell exhaustion. Using that backbone, heterogeneity in combinatorial expression of these fate-selected activation and differentiation molecules allowed us to resolve patterns of Tex cell differentiation in human disease. Together, these observations suggest a model where, within a T cell lineage or fate, cells can exist in multiple states of differentiation and/or activation. Comparing the patterns of Tex cell clusters across disease severity in HIV and between HIV and lung cancer allows speculation about possible relationships between Tex cell subpopulations in a model of T cell exhaustion in humans ( Figure S7) . Notably, this analysis also clearly identified distinct populations with TN, TMEM, TEMRA, TRM, and senescent phenotypes. Thorough understanding of T cell exhaustion is becoming increasingly relevant for improving immunotherapies. The deep phenotyping presented here implicates differential expression of checkpoint blockade targets on different exhaustion subsets and suggests approaches for high-dimensional profiling of Tex cells in checkpoint blockade and other therapeutic interventions. Moreover, this resource should provide an opportunity to further interrogate Tex cell biology in human disease. Thus, these results have implications for our understanding, diagnostics, immune monitoring, and immunomodulatory approaches in chronic infection, autoimmunity, and cancer.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Figures 1, 2, and 3. In Figure S1 , Gene set variation analysis (GSVA) using GSVA R package (H€ anzelmann et al., 2013) was performed to interrogate single cell transcriptomic data from (Tirosh et al., 2016) and assess different exhaustion gene sets in the tumor microenvironment. Briefly, CD8 T cell single-cell data was obtained from NIH GEO (GSE72056), and GSVA of single-cell data was performed using the full epigenomically-and transcriptomically defined exhaustion gene list or a subset of genes later analyzed by CyTOF. The results of the GSVA analysis using the exhaustion gene sets were used to calculate a GSVA exhaustion score (GSVA_score_UP -GSVA_score DN).
Exhaustion function mapping
Exhaustion-specific markers shared between the phenotyping and stimulation panel (''scaffold,'' outlined in Table S6 ) were used to map post-stimulation samples to pre-stimulation clusters by the ''classify'' mode of Phenograph . The training data was constructed by sampling equal amounts of cells (50000) from each of the samples with a stimulus. The exhaustion markers common to both the unstimulated and post stimulation data, CTLA4, CD7, CD127, Helios, PD-1, CCR7, Eomes, CD39, TOX, TIGIT, CXCR5, 2B4, LAG3 were used for these analyses. For each stimulated sample, a nearest neighbor graph using the Jaccard metric was constructed using the training data and cells from the stimulated sample. Random walk probabilities through the graph were used to assign clusters to each of the stimulated cells. See for a more detailed description. The concordance between the mapped and pre-stim data is shown in Figure S4 . A functional exhaustion score (FES) was then calculated using the production of IL-2 and CCL3/4, as well as IFN-g and TNF coproduction (2*(%IFN+TNF-)-(%IFN-TNF+)-(%IL-2+))*(%CCL3/4+).
Heatmap display
Heatmaps were generated using the Pheatmap R package (v. 1.0.8). Color is based on the z-score and indicated by a color palette in the figures next to the heatmaps.
Statistical analysis and data visualization
Statistical analysis was performed using JMP 12.2.0 (SAS), GraphPad Prism 7.02 and R 3.3.1 limma package. Group comparisons in Figures 5, 6 , and 7 were performed using unpaired t test with Welch's correction. In Figures 5 and 6 , simple regression analysis of phenograph cluster frequencies in viremic HIV patient samples was performed versus viral load and the CD4/CD8 ratio. The respective Pearson correlation was plotted using R ggplot2 package. The cluster dot size displayed in Figures 5G and 7C was scaled proportionally to the abundance of individual clusters (% of CD8). In Figures 6 and 7 , sum of the percentage of phenograph clusters per sample was calculated for the top2 and top9 clusters with highest FES shown in Figures 5 and 6 , the Disease-or Health Associated Tex cell clusters in HIV (DAT/HAT) indicated in Figure 6 . In addition a TEX ratio was calculated using the sum of the frequency of DAT divided by the sum of the frequency of HAT to assess a skewing of the composition of different qualities of Tex cells across diseases.
For the box and whisker outlier plots used in Figures 2-4 , 6, and 7, the upper and lower quartile are indicated by the box, and the whiskers span the highest and lowest observations generated using JMP. Whiskers in the bar plot in Figure 7E indicate SEM.
DATA AND SOFTWARE AVAILABILITY
The high-dimensional mass cytometry phenotyping data are available through Cytobank. A summary of the transcriptomic and epigenomic datasets and relevant links to data repositories are provided in the Key Resources Table. 
